|

CD19-CAR-DNT cells Clinical Trials

1 actively recruiting trial

Also known as: Cyclophosphamide, Fludarabine

Pipeline

Phase 1: 1

Top Sponsors

  • RenJi Hospital1

Indications

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
  • Systemic Sclerosis1
  • Systemic Lupus Erythematosus1
  • Idiopathic Inflammatory Myopathies1
  • Lupus1

Other1 trial

Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.